LectinStars Pharmaceuticals showcased at the 2022 BioAsia Asia. Our co-founders' compelling speeches during the company's prospect presentation garnered positive feedback. Our booth attracted corporate representatives and attendees interested in our ongoing research on chronic hepatitis B and other treatments. This exhibition expanded our horizons and set a solid foundation for future partnerships and industry collaboration. We anticipate leveraging this experience to advance our presence in biomedicine, contributing to the company's growth and expansion.